MAPS remains “optimistic about treatment protection, although not naive to the problems”. MDMA therapy will require distinctive protection under insurance plan, medicare, and medicaid. Much more information on protection will arrive as we close to FDA approval. When will other nations around the world authorize MDMA and on what terms?Nonetheles